Newsroom
Sorted by: Latest
-
Inverness Long Term Care Workers Vote to Strike
INVERNESS, NS--(BUSINESS WIRE)--Long term care workers at Inverary Manor, represented by Canadian Union of Public Employees (CUPE) 1485, voted 100% in favour of a strike mandate last week. “We’ve reached a breaking point,” admitted CUPE 1485 President Ashton Brown, “and that can be seen across the province. Long term care workers are overworked and underpaid and when we ask for help, or for recognition of the vital work we do, the government’s response is to offer us almost nothing at the barga...
-
Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
-
Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
-
A NORMAL recolhe a 'Lâmpada UV para unhas de gel'
SKANDERBORG, Dinamarca--(BUSINESS WIRE)--Lâmpada UV para unhas de gel Código de barras: 5744002100249 Modelo do produto: 29 O nosso fornecedor de “Lâmpada UV para unhas de gel”, The Room ApS, identificou um defeito grave no dispositivo de ligação BQ-36, que representa um risco para a segurança. Os clientes devem deixar de usar este produto imediatamente. O produto tem sido vendido em lojas da NORMAL. Os clientes podem devolver o produto a uma loja da Normal. Receberão o reembolso sem necessidad...
-
CTP signs lease with Procter & Gamble for 37,000 sqm flagship facility in Prague
PRAGUE--(BUSINESS WIRE)--Regulatory News: CTP, Europe’s largest listed owner, developer, and operator of logistics and industrial real estate by gross leasable area, has signed a major lease agreement with global consumer goods company Procter & Gamble (P&G) for a new, 37,000 sqm logistics and production facility at CTPark Prague North. This milestone reinforces the park’s position as a leading European logistics hub. Construction of the facility is now underway following a symbolic rai...
-
Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
-
Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
-
Riassunto: Meiji Seika Pharma collaborates con MBC BioLabs per rafforzare l'innovazione globale nella scoperta dei farmaci
TOKYO--(BUSINESS WIRE)--Meiji Seika Pharma Co., Ltd. (Sede: Chuo-ku, Tokyo; Presidente e CEO: Toshiaki Nagasato) oggi ha annunciato la firma di un accordo di collaborazione con MBC BioLabs, un'organizzazione privata che supporta lo sviluppo di aziende startup biotecnologiche nella San Francisco Bay Area californiana. MBC BioLabs fornisce strutture di ricerca completamente attrezzate e una comunità di supporto che aiuta gli imprenditori del settore biotecnologico ad accelerare le operazioni dal...
-
Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
-
Samenvatting: Meiji Seika Pharma gaat samenwerking aan met MBC BioLabs om wereldwijde innovatie op het gebied van geneesmiddelenontwikkeling te versterken
TOKIO--(BUSINESS WIRE)--Meiji Seika Pharma Co., Ltd. (hoofdkantoor: Chuo-ku, Tokio; president en CEO: Toshiaki Nagasato) heeft vandaag bekendgemaakt dat het een samenwerkingsovereenkomst heeft gesloten met MBC BioLabs, een particuliere organisatie die de ontwikkeling van biotechnologische start-ups in de San Francisco Bay Area in Californië ondersteunt. MBC BioLabs biedt volledig uitgeruste onderzoeksfaciliteiten en een ondersteunende gemeenschap die biotechondernemers helpt om sneller van conc...